<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Differential diagnosis of premature pubarche</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Differential diagnosis of premature pubarche</h1>
<div class="graphic"><div class="figure"><div class="ttl">Differential diagnosis of premature pubarche</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="20%"></colgroup><colgroup span="2" width="30%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2"> </td> <td class="subtitle1">Key laboratory findings</td> <td class="subtitle1">Comments</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>Premature adrenarche</strong></td> <td> <p>DHEAS 40 to 115 mcg/dL (1.1 to 3.1 micromol/L)</p> 17OHP normal (&lt;115 ng/dL) or mildly elevated</td> <td>Most common cause of premature pubarche.</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>Idiopathic premature pubarche</strong></td> <td>DHEAS &lt;40 mcg/dL (1.1 micromol/L)</td> <td>Skeletal growth, bone age, and hormone concentrations are normal for preschool-aged children.</td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>Hypertrichosis</strong></td> <td>Normal androgen (C19 steroid hormone) levels</td> <td>Excessive fine (vellus) body hair in both sexual and nonsexual areas (not true pubarche).</td> </tr> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Gene(s) involved</td> <td class="subtitle1">Key laboratory findings</td> <td class="subtitle1">Comments</td> </tr> <tr> <td colspan="4"><strong>Virilizing CAHs</strong></td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/201910" target="_blank">21-hydroxylase deficiency</a></td> <td><em><a href="https://omim.org/entry/613815" target="_blank">CYP21A2</a></em></td> <td>17OHP (8 AM) usually markedly elevated (&gt;200 ng/dL [6 nmol/L])</td> <td>Most common type of CAH; has classic (severe) or nonclassic (mild) forms. The nonclassic form often presents as premature pubarche.</td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/201810" target="_blank">3-beta-hydroxysteroid dehydrogenase type 2 deficiency</a></td> <td><em><a href="https://omim.org/entry/613890" target="_blank">HSD3B2</a></em></td> <td> <p>Intermediate elevations of 17-hydroxypregenolone</p> Elevated DHEA</td> <td>Uncommon type of CAH that may present with premature pubarche.</td> </tr> <tr class="divider_bottom"> <td class="indent1"><a href="https://omim.org/entry/202010" target="_blank">11-beta-hydroxylase deficiency</a></td> <td><em><a href="https://omim.org/entry/610613" target="_blank">CYP11B1</a></em></td> <td> <p>Elevated 11-deoxycortisol concentrations</p> 17OHP concentrations may also be slightly elevated</td> <td>Uncommon type of CAH that may present with premature pubarche.</td> </tr> <tr> <td colspan="4"><strong>Disorders affecting cortisol and DHEAS secretion</strong></td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/604931" target="_blank">Apparent cortisone reductase deficiency</a></td> <td><a href="https://omim.org/entry/138090" target="_blank"><em>H6PD</em></a></td> <td>Reduced ratio of cortisol to cortisone urinary metabolites</td> <td> </td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/614662" target="_blank">Cortisone reductase deficiency</a></td> <td><em><a href="https://omim.org/entry/600713" target="_blank">HSD11B1</a></em></td> <td>Reduced ratio of cortisol to cortisone urinary metabolites</td> <td> </td> </tr> <tr> <td class="indent1">Apparent DHEA sulfotransferase deficiency</td> <td><a href="https://omim.org/entry/603005" target="_blank"><em>PAPSS2</em></a></td> <td> <p>Low DHEAS</p> Elevated DHEA and other unconjugated C19 adrenal steroids</td> <td>Associated with spondyloepimetaphyseal dysplasia.</td> </tr> <tr class="divider_bottom"> <td class="indent1"><a href="https://omim.org/entry/615962" target="_blank">Familial glucocorticoid resistance</a></td> <td><em><a href="https://omim.org/entry/138040" target="_blank">NR3C1</a></em></td> <td>Elevated urinary free cortisol</td> <td>Lack Cushingoid features despite high cortisol.</td> </tr> <tr class="divider_bottom"> <td><strong>Cushing syndrome</strong></td> <td> </td> <td> <p>Elevated late-night salivary cortisol</p> Failure to suppress cortisol and ACTH during an overnight dexamethasone suppression test</td> <td> <p>Cushing syndrome has many causes, including pituitary hypersecretion of ACTH (also known as Cushing disease) or exogenous glucocorticoid administration.</p> Refer to UpToDate content on Cushing syndrome.</td> </tr> <tr> <td colspan="4"><strong>Androgen-secreting tumors</strong></td> </tr> <tr> <td class="indent1">Adrenocortical adenomas or adrenocortical carcinomas</td> <td>Multiple genes</td> <td>DHEAS is typically extremely elevated</td> <td>Virilization, accelerated skeletal maturation, rapid pubertal progression. Some patients have Cushingoid features or hypertension.</td> </tr> <tr> <td class="indent1">Ovarian androgen-secreting tumors</td> <td> </td> <td> <p>Low LH</p> <p>Elevated testosterone</p> DHEAS elevation unusual</td> <td>Virilization, accelerated skeletal maturation.</td> </tr> <tr> <td class="indent1">Testicular androgen-secreting tumors</td> <td> </td> <td> <p>Low LH</p> <p>Elevated testosterone</p> DHEAS elevation unusual</td> <td>Virilization, skeletal maturation, testicular and penile enlargement.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Beta-hCG-secreting tumors (liver, brain, or testicles)</td> <td> </td> <td> <p>Low LH</p> Elevated hCG and, in males, testosterone</td> <td>Virilization, skeletal maturation. Boys have testicular and penile enlargement.</td> </tr> <tr class="divider_bottom"> <td><strong>Central (GnRH-dependent) precocious puberty</strong></td> <td> </td> <td>Elevated LH and estradiol/testosterone</td> <td>Usually presents with breast development in girls or testicular enlargement in boys, which typically precede pubarche. Bone age is advanced.</td> </tr> <tr> <td colspan="4"><strong>GnRH-independent precocious puberty</strong></td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/176410" target="_blank">Familial male-limited precocious puberty</a></td> <td><em><a href="https://omim.org/entry/152790" target="_blank">LHR</a></em></td> <td>Normal male pubertal sex hormone pattern</td> <td> <p>Testicular and penile enlargement.</p> Constitutional activation of the LH receptor gene.</td> </tr> <tr class="divider_bottom"> <td class="indent1"><a href="https://www.omim.org/entry/139320" target="_blank">McCune-Albright syndrome</a></td> <td><a href="https://www.omim.org/entry/174800" target="_blank"><em>GNAS</em></a></td> <td>Elevated estradiol or testosterone; suppressed LH and FSH</td> <td>Café-au-lait skin pigmentation, fibrous dysplasia, macroorchidism.</td> </tr> <tr class="divider_bottom"> <td><strong>Portosystemic shunting</strong></td> <td> </td> <td> <p>Low DHEAS</p> Increased testosterone and androstenedione</td> <td> </td> </tr> <tr> <td><strong>Exogenous androgen exposure</strong></td> <td> </td> <td> <p>Low LH and DHEAS</p> Anabolic steroid detection requires specific LCMSMS methodology</td> <td>Caused by exogenous exposure to androgens, eg, from an androgen-containing cream or anabolic body-building supplement used by adult caregivers and transferred to the child by skin-to-skin contact.</td> </tr> </tbody></table></div><div class="graphic_footnotes">DHEAS: dehydroepiandrosterone sulfate; 

	17OHP: 17-hydroxyprogesterone; 

	CAH: congenital adrenal hyperplasia; 

	DHEA: dehydroepiandrosterone; 

	ACTH: adrenocorticotropic hormone; 

	LH: luteinizing hormone; 

	hCG: human chorionic gonadotropin; 

	GnRH: gonadotropin-releasing hormone; 

	FSH: follicle-stimulating hormone; 

	LCMSMS: liquid chromatography/tandem mass spectrometry.</div><div id="graphicVersion">Graphic 130220 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
